IB

#46
October 5 · 18 min
Biotech Investment Trends in 2026 with Ailin Zhang
In this episode of Inside Biotech, we sit down with Ailin Zhang, a UC Irvine PhD candidate and member of the BCLA Consulting team, to explore biotech investment trends across the U.S. in 2026. We discuss shifts in early- and late-stage venture funding, the rise of licensing and M&A activity, growing investment in AI and biologics, and changing trends across therapeutic modalities. Ailin also shares insights from BCLA’s Card News research and discusses what these trends could mean for biotech sta


















